Influence of NADPH oxidase inhibition on oxidative stress parameters in rat hearts

Pharmacological Reports

Volumn 65, Issue 4, 2013, Pages 898-905

  Kleniewska, Paulina ^a   Michalska, Marta ^a   Goraca, Anna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Apocynin; Endothelin 1; Heart; Reactive oxygen species

Indexed keywords

APOCYNIN; ENDOTHELIN 1; GLUTATHIONE; HYDROGEN PEROXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; HEART; HEART EDEMA; HOMOGENATE; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; RAT; SINGLE DRUG DOSE; WISTAR KYOTO RAT;

ACETOPHENONES; ANIMALS; ANTIOXIDANTS; EDEMA; ENDOTHELIN-1; GLUTATHIONE; LIPID PEROXIDATION; MALE; MYOCARDIUM; NADPH OXIDASE; OXIDATIVE STRESS; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84886482694     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71071-5     Document Type: Article

References (43)

1. Ammarguellat F, Larouche I, Schiffrin EL: Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ETA receptor antagonism. Circulation, 2001, 103, 319-324.
2. Anantharam V, Kaul S, Song C, Kanthasamy A, Kanthasamy AG: Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4- phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. Neurotoxicology, 2007, 28, 988-997.
3. Bedard K, Krause KH: The NOX family of ROSgenerating NADPH oxidases: physiology and pathophysiology. Physiol Rev, 2007, 87, 245-313.
4. Boillee S, Cleveland DW: Revisiting oxidative damage in ALS: microglia, Nox and mutant SOD1. J Clin Invest, 2008, 118, 474-478.
5. Brunner F, Bras-Silva C, Cerdeira AS, Leite-Moreira AF: Cardiovascular endothelins: Essential regulators of cardiovascular homeostasis. Pharmacol Ther, 2006, 111, 508-531.
6. Cheng CM, Hong HJ, Liu JC, Shih NL, Juan SH, Loh SH, Chan P et al.: Crucial role of extracellular signal-regulated kinase pathway in reactive oxygen species-mediated endothelin-1 gene expression induced by endothelin-1 in rat cardiac fibroblasts. Mol Pharmacol, 2003, 63, 1002-1011.
7. Deng B, Xie S, Wang J, Xia Z, Nie R: Inhibition of protein kinase Cb2 prevents tumor necrosis factor-A-induced apoptosis and oxidative stress in endothelial cells: the role of NADPH oxidase subunits. J Vasc Res, 2012, 49, 144-159.
8. Dhalla NS, Elmoselhi AB, Hata T, Makino N: Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res, 2000, 47, 446-456.
9. Dodd-O JM, Pearse DB: Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury. Am J Physiol Heart Circ Physiol, 2000, 279, H303-H312.
10. Donate PB, Cunha TM, Verri WA, Junta CM, Lima FO, Vieira SM, Peres RS et al.: Bosentan, an endothelin receptor antagonist, ameliorates collagen-induced arthritis: the role of TNF-A in the induction of endothelin system genes. Inflamm Res, 2012, 61, 337-348.
11. Duerrschmidt N, Wippich N, Goettsch W, Broemme HJ, Morawietz H: Enothelin-1 induced NAD(P)H oxidase in human endothelial cells. Biochem Biophys Res Commun, 2000, 269, 713-717.
12. Ellman GL: SH groups determination in biological fluids. Anal Biochem, 1970, 46, 237.
13. Elmarakby AA, Loomis ED, Pollock JS, Pollock DM: NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension, 2005, 45, 283-287.
14. Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: malonaldehyde and 4- hydroxynonenal. Methods Enzymol, 1990, 186, 407-421.
15. Filep JG, Fournier A, Földes-Filep E: Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETAreceptor, platelet-Activating factor and thromboxane A2. Br J Pharmacol, 1994, 112, 963-971.
16. Filep JG, Skrobik Y, Fournier A, Földes-Filep E: Effects of calcium antagonists on endothelin-1-induced myocardial ischaemia and oedema in the rat. Br J Pharmacol, 1996, 118, 893-900.
17. Fujita H, Fujishima H, Morii T, Sakamoto T, Komatsu K, Hosoba M, Narita T: Modulation of renal superoxide dis- mutase by telmisartan therapy in C57BL/6-Ins2(akita) diabetic mice. Hypertens Res, 2012, 35, 213-220.
18. Gao F, Yao CL, Gao E, Mo QZ, Yan WL, McLaughlin R, Lopez BL: Enhancement of glutathione cardioprotection by ascorbic acid in myocardial reperfusion injury. J Pharmacol Exp Ther, 2002, 301, 543-550.
19. Grijalva J, Hicks S, Zhao X, Medikayala S, Kaminski PM, Wolin MS, Edwards JG: Exercise training enhanced myocardial endothelial nitric oxide synthase (eNOS) function in diabetic Goto-Kakizaki (GK) rats. Cardiovasc Diabetol, 2008, 19, 7-34. doi: 10.1186/1475-2840- 7-34.
20. Heinroth-Hoffmann I, Vogelsang M, Schiewe P, Morawietz H, Holtz J, Pönicke K, Brodde OE: Mechanism of ETA-receptor stimulation-induced increases in intracellular Ca2+ in SK-N-MC cells. Br J Pharmacol, 1998, 125, 1202-1211.
21. Hong HJ, Chan P, Liu JC, Juan SH, Huang MT, Lin JG, Cheng TH: Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. Cardiovasc Res, 2004, 61, 159-168.
22. Jesmin S, Yamaguchi N, Zaedi S, Nusrat Sultana S, Iwashima Y, Sawamura A, Gando S: Time-dependent expression of endothelin-1 in lungs and the effects of TNF-A blocking peptide on acute lung injury in an endotoxemic rat model. Biomed Res, 2011, 32, 9-17.
23. Kahles T, Luedike P, Endres M, Galla HJ, Steinmetz H, Busse R, Neumann-Haefelin T, Brandes RP: NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke, 2007, 38, 3000-3006.
24. Konopka R, Kubala L, Lojek A, Pachernik J: Alternation of retinoic acid induced neural differentiation of P19 embryonal carcinoma cells by reduction of reactive oxygen species intracellular production. Neuro Endocrinol Lett, 2008, 29, 770-774.
25. Lapperre TS, Jimenez LA, Antonicelli F, Drost EM, Hiemstra PS, Stolk J, MacNee W, Rahman I.: Apocynin increases glutathione synthesis and activates AP-1 in alveolar epithelial cells. FEBS Lett, 1999, 443, 235-239.
26. Ji LL: Antioxidants and oxidative stress in exercise. Proc Soc Exp Biol Med, 1999, 222, 283-292.
27. Li L, Watts SW, Banes AK, Galligan JJ, Fink GD, Chen AF: NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension. Hypertension, 2003, 42, 316-321.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem, 1951, 193, 265-275.
29. Luscher TF, Barton M: Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation, 2000, 102, 2434-2440.
30. Murray DB, Gardner JD, Brower GL, Janicki JS: Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats. Am J Physiol Heart Circ Physiol, 2004, 287, 2295-2299.
31. Pattillo CB, Pardue S, Shen X, Fang K, Langston W, Jourd'heuil D, Kavanagh TJ et al.: ICAM-1 cytoplasmic tail regulates endothelial glutathione synthesis through a NOX4/PI3-kinase-dependent pathway. Free Radic Biol Med, 2010, 49, 1119-1128.
32. Piechota A, Polañczyk A, Goraca A: Protective effects of endothelin-A receptor antagonist BQ123 against LPSinduced oxidative stress in lungs. Pharmacol Rep, 2011, 63, 494-500.
33. Ruch W, Cooper PH, Baggiolini M.: Assay of H2O2 production by macrophages and neutrophils with homovanillic acid and horse-radish peroxidase. J Immunol Methods, 1983, 63, 347-357.
34. Sedeek MH, Llinas MT, Drummond H, Fortepiani L, Abram SR, Alexander BT, Reckelhoff JF, Granger JP: Role of reactive oxygen species in endothelin-induced hypertension. Hypertension, 2003, 42, 806-810.
35. Shimojo N, Jesmin S, Zaedi S, Otsuki T, Maeda S, Yamaguchi N, Aonuma K: Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy. Am J Physiol Heart Circ Physiol, 2007, 293, H474-H481.
36. Sriram S, Subramanian S, Sathiakumar D, Venkatesh R, Salerno MS, McFarlane CD, Kambadur R, Sharma M: Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-kB. Aging Cell, 2011, 10, 931-948.
37. Stefanska J, Sokolowska M, Sarniak A, Wlodarczyk A, Doniec Z, Nowak D, Pawliczak R: Apocynin decreases hydrogen peroxide and nitrate concentrations in exhaled breath in healthy subjects. Pulm Pharmacol Ther, 2010, 23, 48-54.
38. Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ: Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin a methoxy-substituted catechol. Am J Respir Cell Mol Biol, 1994, 11, 95-102.
39. Viswanatha Swamy AH, Wangikar U, Koti BC, Thippeswamy AH, Ronad PM, Manjula DV: Cardioprotective effect of ascorbic acid on doxorubicin-induced myocardial toxicity in rats. Indian J Pharmacol, 2011, 43, 507-511.
40. Woodfin A, Hu DE, Sarker M, Kurokawa T, Fraser P: Acute NADPH oxidase activation potentiates cerebrovascular permeability response to bradykinin in ischemia- reperfusion. Free Radic Biol Med, 2011, 50, 518-524.
41. Wu L, Li X, Li Y, Wang L, Tang Y, Xue M: Proliferative inhibition of danxiongfang and its active ingredients on rat vascular smooth muscle cell and protective effect on the VSMC damage induced by hydrogen peroxide. J Ethnopharmacol, 2009, 126, 197-206.
42. Yagi K: Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol, 1998, 108, 101-106.
43. Yang Z, Sharma AK, Marshall M, Kron IL, Laubach VE: NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. Am J Respir Cell Mol Biol, 2009, 40, 375-381.